首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >MSI phenotype and MMR alterations in familial and sporadic gastric cancer.
【24h】

MSI phenotype and MMR alterations in familial and sporadic gastric cancer.

机译:家族性和散发性胃癌的MSI表型和MMR改变。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Microsatellite instability (MSI) is a major pathway involved in gastric carcinogenesis occurring in 20% of gastric cancer (GC). However, it is not clear whether MSI phenotype preferentially occurs in the sporadic or familial GC, when stringent inclusion criteria are used. The aim of this study was to compare the frequency of MSI and hypermethylation of MLH1 promoter in a large series of familial GC patients (non-HNPCC and non-CDH1-related) and sporadic cases. Additionally, we analysed the immunoexpression of MMR proteins in a fraction of cases. Overall, the frequency of familial GC was 7.1%, and the frequency of hereditary tumours was 4.6%. MSI phenotype and MLH1 hypermethylation frequencies were not statistical different between familial and sporadic GC settings. Further, the MSI phenotype was not associated with any clinico-pathological features studied in the familial GC setting, whereas in the sporadic setting, it was associated with older age, female gender and intestinal histotype. Using our stringent Amsterdam-based clinical criteria to select familial GC (number of cases, age of onset), we verified that sporadic and familial cases differed in gender but shared histopathological features. We verified that the frequency of MSI was similar in familial and sporadic GC settings, demonstrating that this molecular phenotype is not a hallmark of familial GC in contrast to what is verified in HNPCC. Moreover, we observed that the frequency of MLH1 hypermethylation is similar in sporadic and familial cases suggesting that in both settings MSI is not associated to MMR genetic alterations but in contrast to epigenetic deregulation.
机译:微卫星不稳定性(MSI)是20%的胃癌(GC)中发生胃癌的主要途径。但是,当使用严格的纳入标准时,尚不清楚MSI表型是否优先出现在散发性或家族性GC中。这项研究的目的是比较一系列家族性GC患者(非HNPCC和非CDH1相关)和散发性病例的MSI频率和MLH1启动子超甲基化。此外,我们分析了少数病例中MMR蛋白的免疫表达。总体而言,家族性GC的发生率为7.1%,遗传性肿瘤的发生率为4.6%。在家族性和散发性GC设置之间,MSI表型和MLH1高甲基化频率无统计学差异。此外,MSI表型与家族性GC环境中研究的任何临床病理特征均不相关,而在散发性环境中,其与年龄,女性性别和肠道组织型相关。使用我们基于阿姆斯特丹的严格临床标准选择家族性GC(病例数,发病年龄),我们验证了偶发和家族性病例的性别不同,但具有组织病理学特征。我们验证了在家族性和散发性GC设置中MSI的发生频率相似,表明与HNPCC中验证的相比,该分子表型不是家族性GC的标志。此外,我们观察到在散发性和家族性病例中MLH1甲基化的频率相似,这表明在两种情况下,MSI与MMR遗传改变无关,但与表观遗传失调相反。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号